Fangfang Xu

399 Middle Yan Chang Road
Shanghai, 200072, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 20 publications

Genomic characterization of uterine adenomatoid tumors reveals recurrent alterations in KMT5A and KMT2C.

Genomic characterization of uterine adenomatoid tumors reveals recurrent alterations in KMT5A and KMT2C.

Journal: Clinical epigenetics

Published: November 18, 2025

Environmental bisphenols hijack the Hmox1 and Cdh1 to trigger premature ovarian insufficiency: A multi-omics investigation.

Environmental bisphenols hijack the Hmox1 and Cdh1 to trigger premature ovarian insufficiency: A multi-omics investigation.

Journal: Ecotoxicology and environmental safety

Published: September 20, 2025

Integrating necroptosis and immune landscapes: a multi-omics-derived NecropImmScore stratifies prognosis and therapy in ovarian cancer.

Integrating necroptosis and immune landscapes: a multi-omics-derived NecropImmScore stratifies prognosis and therapy in ovarian cancer.

Journal: Cancer immunology, immunotherapy : CII

Published: July 09, 2025

NAD+ Metabolism-Mediated SURF4-STING Axis Enhances T-Cell Anti-Tumor Effects in the Ovarian Cancer Microenvironment.

NAD+ Metabolism-Mediated SURF4-STING Axis Enhances T-Cell Anti-Tumor Effects in the Ovarian Cancer Microenvironment.

Journal: Cell death & disease

Published: March 16, 2025

Decoding adenomyosis pathogenesis using an assembloid model.

Decoding adenomyosis pathogenesis using an assembloid model.

Journal: Science China. Life sciences

Published: January 10, 2025

Integrated analyses reveal CXCL11 as an inhibitor in ovarian cancer and its facilitation of an M1 macrophage switch via the JAK2/STAT1 pathway.

Integrated analyses reveal CXCL11 as an inhibitor in ovarian cancer and its facilitation of an M1 macrophage switch via the JAK2/STAT1 pathway.

Journal: International immunopharmacology

Published: November 22, 2024

Dual Role of Necroptosis in Cervical Cancer: Promoting Tumor Aggression and Modulating the Immune Microenvironment via the JAK2-STAT3 Pathway.

Dual Role of Necroptosis in Cervical Cancer: Promoting Tumor Aggression and Modulating the Immune Microenvironment via the JAK2-STAT3 Pathway.

Journal: Journal of Cancer

Published: May 21, 2024

Immunoreactive Microenvironment Modulator GBP5 Suppresses Ovarian Cancer Progression by Inducing Canonical Pyroptosis.

Immunoreactive Microenvironment Modulator GBP5 Suppresses Ovarian Cancer Progression by Inducing Canonical Pyroptosis.

Journal: Journal of Cancer

Published: January 23, 2024

Transplantation of the LRP1high subpopulation of human umbilical cord-derived mesenchymal stem cells improves ovarian function in mice with premature ovarian failure and aged mice.

Transplantation of the LRP1high subpopulation of human umbilical cord-derived mesenchymal stem cells improves ovarian function in mice with premature ovarian failure and aged mice.

Journal: Stem cell research & therapy

Published: November 22, 2023

A novel lipid metabolism-related lncRNA signature predictive of clinical prognosis in cervical cancer.

A novel lipid metabolism-related lncRNA signature predictive of clinical prognosis in cervical cancer.

Journal: Frontiers in genetics

Published: July 23, 2022

Comprehensive analyses identify RIPOR2 as a genomic instability-associated immune prognostic biomarker in cervical cancer.

Comprehensive analyses identify RIPOR2 as a genomic instability-associated immune prognostic biomarker in cervical cancer.

Journal: Frontiers in immunology

Published: April 28, 2022

Identification of a Ferroptosis-Related Prognostic Gene PTGS2 Based on Risk Modeling and Immune Microenvironment of Early-Stage Cervical Cancer.

Identification of a Ferroptosis-Related Prognostic Gene PTGS2 Based on Risk Modeling and Immune Microenvironment of Early-Stage Cervical Cancer.

Journal: Journal of oncology

Published: January 18, 2022

Showing 1-12 of 20

Last Updated: 09/26/2026